INTRODUCTION
Because preimplantation genetic diagnosis (PGD) involves genetic analysis in single cells, its accuracy depends on the controlling the limitations of single-cell 1 Reproductive Genetics Institute, 836 West Wellington Avenue, Chicago, Illinois 60657. 2 To whom correspondence should be addressed.
1058-0468/99/0400-0l92$16.00/0 © 1999 Plenum Publishing Corporation 192 polymerase chain reaction (PCR) analysis, which include allele dropout (ADO). It has been demonstrated that single-cell ADO rates vary with different cell types and loci analyzed (1) (2) (3) (4) . This makes the development of methods for efficient detection of ADO desirable, to minimize misdiagnosis in PGD of single-gene disorders. We have recently introduced a sequential analysis of the first (I) and second (II) polar body (PB) for preselection of mutation-free oocytes, in addition to simultaneous amplification of mutant genes and linked polimorphic markers, to detect ADO and avoid misdiagnosis (4, 5) . In the present paper, the impact of the application of both of these approaches for PGD of different single-gene disorders was studied, demonstrating their accuracy in detecting ADO and avoiding misdiagnosis in PGD of single-gene disorders.
MATERIALS AND METHODS
Forty-eight in vitro fertilization cycles in 26 couples were performed for PGD of the following single-gene disorders: cystic fibrosis (CF)(AF-508 and G551D), thalassemia (IVSI-110, IVSI-6, and IVSII-745), sickle cell disease, Gaucher disease, hemophilia B, and longchain acyl-CoA dehydrogenase deficiency (LCHAD). This includes some data from the PGD cycles described elsewhere (4, 6, 7) . PGD was performed by genetic analysis of the IPB and IIPB, removed from oocytes after maturation and fertilization, using micromanipulation techniques. Genetic analysis was based on multiplex nested PCR analysis, with the introduction of primers for the mutant genes and polymorphic markers in the first round (4) . Primer sequences, reaction conditions, and details of the nested PCR reaction for PGD of the majority of the above single-gene disorders have been described (1, 4, 6) . The strategies for PGD for Gaucher disease, CFTR G551D, and LCHAD are presented in Figs. 1-3 and Table I . In addition to short tandem repeats (STRs) linked to the genes studiod, STRs located on other chromosomes were also studied to test possible contamination by extraneous DNA. The following STRs were tested: THO 1, F13A1, FES/FPS, vWF, D21S11, and CSFIR. To investigate the accuracy of PB PGD diagnosis, the embryos resulting from oocytes predicted to contain a mutant maternal allele were exposed to confirmatory PCR analysis. 
RESULTS AND DISCUSSION
Five hundred twenty-nine oocytes were obtained from 48 clinical cycles of 26 patients at risk for having children with single-gene disorders, including 17 cycles for thalassemia, 6 for sickle cell disease, 21 for CF, 2 for LCHAD, 1 for hemophilia B, and 1 for Gaucher disease. Of these 529 oocytes, 331 (62.6%) were heterozygous after IPB genetic analysis, so their potential transfer depended on the sequential analysis of the IIPB. No heterozygous oocytes were observed in PGD of Gaucher disease. This is not surprising, as the gene is mapped close to the centromere of chromosome 1. Of all six oocytes studied whose IPBs were homozygous, three were predicted normal and transferred, while the other three, predicted to be abnormal, were confirmed to contain a mutant gene, based on the follow-up study of the embryos resulting from these oocytes (Fig. 4) .
The data from both the IPB and the IIPB were available in 318 of 529 oocytes, making it possible to in the absence of polymorphic marker analysis, the predict the genotype of 285 oocytes, including 203 homozygous status of such oocytes cannot be distinderived from those with heterozygous IPBs, of which guished from ADO in oocytes with a heterozygous 142 were mutation-free and 153 were affected (Table  IPB. In fact, ADO was detected in 24 (7.2%) of 318 II). Of 142 mutation-free oocytes, the genotype of oocytes studied, of which 18 (5.4%) were detected only 42 (29.6%) could have been predicted normal solely by the sequential IPB and IIPB analysis, and 6 following meiosis I (based on IPB analysis). However, (1.8%) by the use of polymorphic markers (Table III) . a Conditions for the second-round PCR for the Intron 6 PvuII polymorphism and mutation 1528 of LCHAD were the same as for the exon 10 (1448C) mutation. * Cells were lysed in 5 ul of lysis buffer at 45°C for 15 min and then proteinase K was destroyed by incubation at 95°C for 20 min. For example, ADO in 2 of 15 oocytes was detected by sequential analysis of the IPB and IIPB in the case of PGD of LCHAD, which is obvious from the homozygous mutant state for both the IPB and the IIPB, suggesting ADO of a normal allele in a heterozygous IPB (Fig. 5) . The follow-up study of the embryos resulting from these oocytes, as well as in similar cases of PGD of other conditions, confirmed the PB diagnosis in 157 (98%) of 160 embryos for which confirmation analysis was available (Table IV) .
Similar results were obtained for analysis of polymorphic markers, which was performed in 459 7 STRs, confirmed the PB PGD in 296 of 307 embryos studied, suggesting a 96% accuracy of PGD (Table IV) .
Of 48 clinical cycles performed for PGD of singlegene disorders listed, normal embryos for transfer were preselected in 44 of them. Of a total of 529 oocytes tested, 318 had data for both the IPB and the IIPB, indicating the mutation-free status in 106 of these oocytes. The transfer of corresponding embryos resulted in 17 (36.6%) pregnancies, of which 6 children have already been born. The availability of approximately six or seven oocytes per cycle with data for both the IPB and the IIPB made it possible to preselect at least two or three mutation-free oocytes for transfer per cycle. The method, therefore, may be acceptable for clinical practice, as it allows preselection of a sufficient number of mutation-free embryos for transfer and provides the possibility to minimize misdiagnosis due to ADO. Further optimization of the method may completely avoid the risk of misdiagnosis due to ADO and other limitations of single-cell PCR analysis for PGD of single-gene disorders.
oocytes. Two hundred eighty-nine (63%) oocytes were heterozygous after IPB analysis, with ADO observed in 22 oocytes (7%), of which 19 (6.5%) were detected, including 17 (5.9%) detected by sequential analysis of the IPB and IIPB and 2 (0.6%) by the use of STRs (Table HI) . The follow-up analysis of 147 embryos for the polymorphic markers studied confirmed the PB diagnosis in 139 cases (96%). Overall, the follow-up analysis for all 16 loci, including 9 mutant alleles and 
